Surgery vs non-surgery in cutaneous melanoma based on SEER database: A cross-sectional study
Yingnan Liu1, Dazhi Yang2, Xiaokuan Fu1
1Department of Hand and Microvascular Surgery.
Medicine
|March 25, 2021
Summary
Surgery significantly improves survival outcomes for cutaneous melanoma (CM) patients. This study used propensity score weighting to compare survival rates, finding that surgical treatment is linked to a lower risk of death in CM patients.
Area of Science:
- Oncology
- Surgical Oncology
- Biostatistics
Background:
- Cutaneous melanoma (CM) is a significant public health concern.
- Treatment decisions, particularly surgery, can impact patient survival.
- Robust statistical methods are needed to accurately assess treatment efficacy.
Purpose of the Study:
- To evaluate the survival outcomes of cutaneous melanoma patients who underwent surgery versus those who did not.
- To apply inverse probability of treatment weighting (IPTW) using propensity scores for a more accurate comparison.
Main Methods:
- Utilized the Surveillance, Epidemiology, and End Results (SEER) database to identify 2203 CM patients.
- Employed propensity score analysis and IPTW to adjust for confounding factors between surgery and non-surgery groups.
- Estimated survival outcomes using hazard ratios (HR) and confidence intervals (CI).
Main Results:
- The IPTW-weighted cohort showed a median survival of 130 months for the surgery group versus 75 months for the non-surgery group.
- Surgical treatment was associated with a significantly lower risk of death (HR: 0.423, P < .001) in the weighted cohort.
- Both unmatched and matched cohorts also indicated improved survival with surgery.
Conclusions:
- Surgical intervention is associated with substantially better survival outcomes for cutaneous melanoma patients.
- IPTW using propensity scores provides a reliable method for comparing survival in observational studies.
- These findings support the role of surgery in managing CM and improving patient prognosis.
Related Concept Videos
Skin Cancer
5.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.1K
Comparing the Survival Analysis of Two or More Groups
388
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
388
Cancer Survival Analysis
508
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
508


